MMP9 and endometriosis: Metformin treatment of endometriosis has been used, which decreases the expression levels of critical inflammatory and angiogenesis-related genes including VEGF, MMP2, and MMP9, while stimulating tissue inhibitors of metalloproteinase, endometrial stromal cells, and progesterone receptor expression [37].